Compare National Immunotherapy Cancer Research Foundation Inc vs Merck Patient Assistance Program Inc for a donation or grant decision: revenue, assets,…
| Metric | National Immunotherapy Cancer Research Foundation Inc | Merck Patient Assistance Program Inc |
|---|---|---|
| EIN | 223067246 | 10575520 |
| State | NJ | NJ |
| City | Flemington | Rahway |
| NTEE Code | H30Z | T210 |
| Revenue | $526K | $1.9B |
| Assets | $1.2M | $26.4M |
| Mission Score | 45/100 | 98/100 |
| Red Flags | 4 | 1 |
| Strengths | 2 | 5 |
National Immunotherapy Cancer Research Foundation Inc: National Immunotherapy Cancer Research Foundation: High Assets, Low Program Spending
Merck Patient Assistance Program Inc: Merck Patient Assistance Program consistently disburses 100% of its nearly $2 billion annual revenue directly to programs.
AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.